Screening of furanocoumarin derivatives in citrus fruits by enzyme-linked immunosorbent assay

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 7, 2004, Pages 974-977

  Saita, Tetsuya ^a   Fujito, Hiroshi ^a   Mori, Masato ^a  

^a SAGA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Citrus fruit; Enzyme linked immunosorbent assay; Furanocoumarin derivative; Grapefruit juice; Screening

Indexed keywords

6',7' DIHYDROXYBERGAMOTTIN; ANTIBODY; BERGAMOTTIN; BETA GALACTOSIDASE; CYTOCHROME P450 3A4; FUROCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG; PSORALEN DERIVATIVE;

ARTICLE; CITRUS FRUIT; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAPEFRUIT JUICE; IMMUNIZATION; IMMUNOADSORBENT; NONHUMAN; PUMMELO; RABBIT; SCREENING; SOUR ORANGE; BEVERAGE; CHEMISTRY; DOSE RESPONSE; ENZYMOLOGY; FRUIT; ISOLATION AND PURIFICATION; METHODOLOGY;

BEVERAGES; CITRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FRUIT; PSORALENS;

EID: 16644390166     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.974     Document Type: Article

References (19)

1. Bailey D. G., Spence J. D., Munoz C., Arnold J. M. O., Lancet, 337, 268-269 (1991).
2. Ducharme M. P., Warbasse L. H., Edwards D. J., Clin. Pharmacol. Ther., 57, 485-491 (1995).
3. Bailey D. G., Arnold J. M. O., Spence J. D., Br. J. Clin. Pharmacol., 46, 101-110 (1998).
4. Dresser G. K., Bailey D. G., Carruthers S. G., Clin. Pharmacol. Ther., 68, 28-34 (2000).
5. Christensen H., Asberg A., Holmboe A.-B., Berg K. J., Eur. J. Clin. Pharmacol., 58, 515-520 (2002).
6. Schmiedlin-Ren P., Edwards D. J., Fitzsimmons M. E., He K., Lown K. K., Woster P. M., Rahman A., Thummel K. E., Fisher J. M., Hollemberg P. F., Watkins P. B., Drug Metab. Dispos., 25, 1228-1233 (1997).
7. Lown K. S., Bailey D. G., Fontana R. J., Janardan S. K., Adair C. H., Fortlage L. A., Brown M. B., Guo W., Watkins P. B., J. Clin. Invest., 99, 2545-2553 (1997).
8. Edwards D. J., Bellevue F. H., Woster P. M., Drug Metab. Dispos., 24, 1287-1290 (1996).
9. Fukuda K., Ohta T., Oshima Y., Ohashi N., Yoshikawa M., Yamazoe Y., Pharmacogenetics, 7, 391-396 (1997).
10. Guo L.-Q., Fukuda K., Ohta T., Yamazoe Y., Drug Metab. Dispos., 28, 766-771 (2000).
11. Pathak M. A., Daniels F., Fitzpatrick T. B., J. Invest. Dermatol., 39, 225-239 (1962).
12. Beier R. C., Rev. Environ. Contam. Toxicol., 113, 47-137 (1990).
13. Namba T., "Coloured Illustrations of Wakan-Yaku, (The Crude Drugs in Japan, China and the Neighbouring Countries)," Hoikusha Publishing, Osaka, 1980, in Japanese with English index.
14. Onoue K., Yagi Y., Pressman D., J. Immunol., 92, 173-184 (1964).
15. Bellevue F. H., Woster P. M., Edwards D. J., He K., Hollenberg P. F., Bioorg. Med. Chem. Lett., 7, 2593-2598 (1997).
16. He K., Iyer K. R., Hayes R. N., Sinz M. W., Woolf T. F., Hollenberg P. F., Chem. Res. Toxicol., 11, 252-259 (1998).
17. Ohta T., Nagahashi M., Hosoi S., Tsukamoto S., Bioorg. Med. Chem., 10, 969-973 (2002).
18. Malhotra S., Bailey D. G., Paine M. F., Watkins P. B., Clin. Pharmacol. Ther., 69, 14-23 (2001).
19. Bailey D. G., Dresser G. K., Bend J. R., Clin. Pharmacol. Ther., 73, 529-537 (2003).